Transcranial Direct Current Stimulation for Motor Function and Fatigue in PD

{ "Transcranial Direct Current Stimulation for Parkinson's Disease Motor Function and Fatigue", "This study is exploring if transcranial direct current stimulation (tDCS) can help improve motor function (movement) and reduce fatigue in people with Parkinson's Disease (PD). Researchers believe that tDCS, a non-invasive brain stimulation technique, might lead to lasting improvements. You might be able to join if you have a clinical diagnosis of PD with at least two of the four main symptoms (tremor, rigidity, slow movement, or balance issues) and can give consent. People with dementia, deep brain stimulation (DBS), psychosis, multiple sclerosis, or stroke cannot participate. The study will measure success by looking at finger and toe-tapping ability using a device called KinesiaOne. The current status of this study is unclear, and it plans to enroll 64 participants.", "design": "This is an interventional study, meaning participants will receive a specific treatment. It plans to enroll 64 participants to test transcranial direct current stimulation (tDCS) against a sham (no treatment) device.", "commitments": "Participants will receive either tDCS or a sham treatment for 20 minutes a day for 5 consecutive days. There will be multiple research visits, including pre-treatment, post-treatment, and follow-up tests.", "compensation": "Not stated in the trial record.", "follow_up": "Participants will have follow-up tests 7 days and 14 days after their last tDCS session.", }

Study design
Not specified.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Not specified.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06883266

Transcranial Direct Current Stimulation for Motor Function and Fatigue in PD

Recruiting
NAAll AgesInterventionalTreatment
Sanford Health
~64 participants
Updated 2026-02-03 on ClinicalTrials.gov
What's tested:transcranial direct current stimulation (tDCS)Sham (No Treatment)

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Finger and Toe-Tapping on KinesiaOne Device
Measured over 30 minutes; pre-test during the second research visit, post-test on 6th research visit after 5 consecutive days of tDCS, a follow up test on the 7th research visit, 7 days after last tDCS session and 8th visit 14 days after last tDCS session
Parkinsons Disease (PD)

NCT06883266

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Sanford Brain and Spine Center

    Fargo, North Dakotastudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

  • Jau-Shin Lou, MD · PRINCIPAL_INVESTIGATOR · Sanford Health

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Clinical diagnosis of PD with at least two of the four diagnostic criteria for PD (tremor, rigidity, bradykinesia, and postural instability)
Must be able to consent

Exclusion

Patients with dementia (MOCA \< 21)
PD treatment using deep brain stimulation (DBS)
Diagnosis of psychosis
Diagnosis of multiple sclerosis
Diagnosis of stroke
Diagnosis of chronic obstructive pulmonary disease (COPD)
Diagnosis of congestive heart failure (CHF)
  • Finger and Toe-Tapping on KinesiaOne Device30 minutes; pre-test during the second research visit, post-test on 6th research visit after 5 consecutive days of tDCS, a follow up test on the 7th research visit, 7 days after last tDCS session and 8th visit 14 days after last tDCS session

    We will use the KinesiaOne measure the finger tapping and foot tapping for 15 seconds. It will repeat 3 times at 1 minute intervals. KinesiaOne is a light-weight device that can be attached to the Index finger or ankle. It measures the acceleration and deceleration of the finger or foot. The measurement is transmitted to the KinesiaOne tablet that allows further data processing.